A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Totus Medicines
Totus Medicines
National Institutes of Health Clinical Center (CC)
Acrivon Therapeutics
Artios Pharma Ltd
Ensem Therapeutics
Eli Lilly and Company
AstraZeneca
Memorial Sloan Kettering Cancer Center
Faeth Therapeutics
AstraZeneca
Johns Hopkins University
VA Office of Research and Development
Zhuhai Yufan Biotechnologies Co., Ltd